Ming-Sound Tsao
曹明声
MD, FRCPC
Senior Scientist and Professor, Department of Laboratory Medicine and Pathobiology高级科学家兼教授，实验室医学与病理生物学系
👥Biography 个人简介
Canada's foremost lung cancer pathologist, internationally recognized for molecular biomarker standardization in NSCLC. Pioneered systematic approaches to EGFR, ALK, and ROS1 testing in lung cancer, contributing to CAP/IASLC/AMP guideline development and global assay harmonization.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
EGFR/ALK Testing Guidelines
Co-authored the landmark CAP/IASLC/AMP molecular testing guidelines for lung cancer, establishing evidence-based recommendations for EGFR, ALK, ROS1, and KRAS testing that became global standard of care.
Lung Cancer Tissue Management
Developed protocols for optimal tissue management in small lung biopsies and cytology specimens, enabling comprehensive molecular profiling from limited samples and reducing need for repeat procedures.
Representative Works 代表性著作
Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment with Targeted Therapies
Journal of Thoracic Oncology (2022)
Co-authored comprehensive updated CAP/IASLC/AMP guidelines recommending broad molecular testing including NGS panels as standard for advanced NSCLC.
Tissue Management Strategy for Optimal Molecular Profiling of Non-Small Cell Lung Cancer
Modern Pathology (2023)
Established evidence-based framework for specimen triaging and processing to maximize yield of actionable molecular results.
🏆Awards & Recognition 奖项与荣誉
📄Data Sources 数据来源
Last updated: 2026-01-15 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 曹明声 的研究动态
Follow Ming-Sound Tsao's research updates
留下邮箱，当我们发布与 Ming-Sound Tsao（Princess Margaret Cancer Centre, University of Toronto）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment